logo

For the Inventor, By the Inventor

Budapest, Hungary

Kalman Takacs

This inventor holds 16 USPTO granted patents. Top assignees: Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., Chinoin Pharmaceutical and Chemical Works Ltd., N-Gene Research Laboratiories Inc.. Active years: 1976-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kalman Takacs. Retrieved from https://idiyas.com/inventor/kalman-takacs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 87.5

Average Co-Inventor Count = 6.6

ph-index = 6

Forward Citations = 92(Granted Patents)


Company Filing History:

goldMedal11 out of 283 
 
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
 patents
silverMedal3 out of 5 
 
Chinoin Pharmaceutical and Chemical Works Ltd.
 patents
bronzeMedal1 out of 1 
 
N-Gene Research Laboratiories Inc.
 patent
4. 1 out of 14 
 
N-Gene Research Laboratories, Inc.
 patents

Years Active: 1976-2006

Loading Chart...
16 patents (USPTO):Explore Patents
1. 7151175 - Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same (2006-12-19),
2. 6887872 - Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same (2005-05-03),
3. 5278309 - Highly pure amidoximes (1994-01-11),
4. 5239077 - Highly pure amidoximes (1993-08-24),
5. 5218117 - Process for preparing isoquinoline compounds (1993-06-08),
6. 5179089 - Isoquinoline compounds, compositions and use (1993-01-12),
7. 4861888 - Process for the preparation of 3,4-dihydroisoquinoline (1989-08-29),
8. 4425349 - Sulfur-containing isoquinoline derivatives in pharmaceutical (1984-01-10),
9. 4373104 - Sulfur-containing isoquinoline derivatives, process for the preparation (1983-02-08),
10. 4365064 - 1,2,4-Oxadiazolin-5-one derivatives, process for their preparation and (1982-12-21),
11. 4308399 - O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the (1981-12-29),
12. 4308270 - 1,2,4-Oxadiazine derivatives, process for their preparation and (1981-12-29),
13. 4187220 - New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the (1980-02-05),
14. 4163786 - Thiazoloisoquinolines with coronary and respiratory effects (1979-08-07),
15. 4062850 - Thiazoloisoquinolines with coronary and respiratory effects (1977-12-13),

Title: Kalman Takacs: Innovator in Pharmaceutical Chemistry

Introduction

Kalman Takacs is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 16 patents. His work focuses on innovative compounds that address critical health issues.

Latest Patents

One of his latest patents is titled "Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same." This invention refers to novel propenecarboxylic acid amidoxime derivatives, including N-oxides, geometrical isomers, optical isomers, and pharmaceutically suitable acid addition salts. The novel compounds are designed for the treatment of conditions related to oxygen and energy deficits, as well as diseases linked to PARP inhibition, particularly autoimmune and neurodegenerative diseases, viral diseases, and conditions caused by toxic effects.

Career Highlights

Throughout his career, Kalman Takacs has worked with prominent companies in the pharmaceutical industry, including Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. and Chinoin Pharmaceutical and Chemical Works Ltd. His experience in these organizations has contributed to his expertise and innovative capabilities in developing new pharmaceutical solutions.

Collaborations

Kalman has collaborated with notable colleagues such as Antal Simay and Ilona Kiss Nee Ajzert. These partnerships have further enriched his research and development efforts in the pharmaceutical field.

Conclusion

Kalman Takacs stands out as a significant figure in pharmaceutical innovation, with a focus on developing compounds that address critical health challenges. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…